Drug Trial Radar · NCT00032929
Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
Last checked: Nov 20, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
269
Actual
Start
Mar 2001
Primary completion
Dec 2002
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- Somerset Pharmaceuticals
- First posted
- Apr 8, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.
Conditions
- Cocaine-Related Disorders
Interventions
SelegilineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Weekly mean proportion of cocaine non-use days
- Measured reductions in cocaine and other drug use
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Tucson VA Medical Center
Tucson, Arizona
Haight-Ashbury Free Clinic
Berkeley, California
Friends Research Institute-2
Los Angeles, California
Friends Research Institute
Los Angeles, California
San Francisco General Hosptial
San Francisco, California
San Francisco VA Medical Center
San Francisco, California
Denver VA Medical Center
Denver, Colorado
New Orleans VA Medical Center
New Orleans, Louisiana
VA Maryland Healthcare System
Baltimore, Maryland
Wayne State University
Detroit, Michigan
Cincinnati VA Medical Center
Cincinnati, Ohio
Medical University of South Carolina
Charleston, South Carolina
VA North Texas Health Care System
Dallas, Texas
University of Texas Hlth Sci Ctr Houston
Houston, Texas
Salt Lake City VA Medical Center
Salt Lake City, Utah
VA Puget Sound Health Care System
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.